-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $250

Benzinga·08/12/2026 13:50:12
Listen to the news
Mizuho analyst Steven Valiquette maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $240 to $250.